HealthResearcher Puzzled Over New Alzheimer’s Drug Approval

Researcher Puzzled Over New Alzheimer’s Drug Approval

-

- Advertisment -sslate

News this week about a breakthrough treatment for Alzheimer’s disease is getting mixed reactions from some researchers, including in Texas.

The drug attempts to treat a possible cause of the neurodegenerative disease, rather than only treating the symptoms.

Dr. George Perry, professor and Semmes Foundation Distinguished University Chair in Neurobiology at the University of Texas at San Antonio and editor of the Journal of Alzheimer’s Disease, the largest subscriber publication in the field, said the announcement by the U.S. Food and Drug Administration (FDA) was a surprise, and for him, a disappointment.

Alzheimer

“The trial that was done had over 3,000 people, cost over $1.5 billion to do, it was done exceptionally well. Now, the analysis that of the data after, mathematically, was ridiculous,” Perry asserted.

On Friday, a prominent Harvard drug researcher became the third member of the FDA’s advisory committee to resign over the agency’s decision to approve aducanumab, saying he’s not convinced of its effectiveness. Harvard’s Aaron Kesselheim called the FDA approval “probably the worst drug approval decision in recent U.S. history.”

Researchers, such as Perry, said the FDA’s decision to green-light the drug might discourage development of other treatments with greater cognitive benefits. He believes its approval could set the research community back 10 to 20 years.

alz

“This was reviewed by a panel of experts; not experts in Alzheimer’s disease, experts in data analysis for drug approval,” Perry explained. “Eleven of them said that the data didn’t show effectiveness, and one of them abstained, and the FDA approved it anyway.”

In Texas, the Alzheimer’s Association said at least 400,000 people are currently living with Alzheimer’s, with an anticipated increase in cases of more than 22% expected by 2025.

Drug-maker Biogen has priced the drug at $56,000 a year for an average patient, but said the vast majority of Alzheimer’s patients will be covered by Medicare, as many are over age 65.

Sunshine Slate
Sunshine Slatehttps://www.sunshineslate.com
Sunshine Slate is your news, entertainment, music fashion website. We provide you with the latest breaking news and videos straight from the United States of America.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

5 FAQs to Corporate Executive Apartments in Raleigh, NC

Here are answers to the top 5 FAQs on executive rentals in Raleigh, NC

Top Huda Beauty Lipstick Shades to Buy Online

A lipstick helps a woman achieve the perfect look. In other words, every woman must have a decent collection of lipsticks.

PERLIE’s Comfort Men’s Shoes Are Taking America By Storm

PERLIE’s unique and patented technology combining sneaker comfort with the looks and quality of luxury men’s shoes, has taken America by storm

Small businesses show their community spirit with support and solidarity in challenging times

New research shows the incredible camaraderie and resilience that exists among small business owners in the face of ongoing challenges.
- Advertisement -

Florida Nonprofit Helps Offset High Cost of Insulin

November is National Diabetes Awareness Month, a time to bring attention to a disease affecting more than 37 million Americans,

Can Wheel Spacers Cause Vibration at High Speed

Wheel spacers are important for your vehicles. This article shows us whether wheel spacers cause vibration.
edealo.com
- Advertisement - Motel 6
transformerscon

Must read

Top Huda Beauty Lipstick Shades to Buy Online

A lipstick helps a woman achieve the perfect look. In other words, every woman must have a decent collection of lipsticks.

Best Apps for your New Mobile Phone

We can install any app from the google play store very quickly. Let’s take a look at some most amazing apps for android mobile phones.
- Advertisement -
- Advertisement -sslate

You might also likeRELATED
Recommended to you